Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and BioMarin Pharmaceutical (BMRN)

TipRanksMay 23 10:20 ET

Novavax Analyst Ratings

BenzingaMay 23 09:26 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaMay 23 07:13 ET

RBC Capital Sticks to Its Hold Rating for PTC Therapeutics (PTCT)

TipRanksMay 22 21:45 ET

Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Lipella Pharmaceuticals, Inc. (LIPO)

TipRanksMay 22 13:10 ET

Buy Rating Affirmed for Crinetics Pharmaceuticals Amid Promising Atumelnant Data for CAH

TipRanksMay 22 09:55 ET

Hold Rating on PTC Therapeutics Amid Regulatory Uncertainty for Translarna

TipRanksMay 22 00:55 ET

United Therapeutics Analyst Ratings

BenzingaMay 21 12:11 ET

PTC Therapeutics Analyst Ratings

BenzingaMay 21 10:14 ET

Chardan Raises Price Target on Dyne Therapeutics to $42 From $31, Cites Additional Positive Data on DYNE-101, DYNE-251; Buy Rating Kept

MT NewswiresMay 21 07:17 ET

Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS), Conmed (CNMD) and PTC Therapeutics (PTCT)

TipRanksMay 21 05:42 ET

Barclays Sticks to Its Hold Rating for Amgen (AMGN)

TipRanksMay 21 03:46 ET

Translarna's Uncertain Future: Justifying a Sell Rating for PTC Therapeutics

TipRanksMay 20 19:15 ET

Sell Rating Maintained for PTC Therapeutics Amid Long-Term Revenue Growth Concerns

TipRanksMay 20 14:45 ET

PTC Therapeutics Analyst Ratings

BenzingaMay 20 13:33 ET

Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD) and Dyne Therapeutics (DYN)

TipRanksMay 20 12:20 ET

Dyne Therapeutics Analyst Ratings

BenzingaMay 20 09:30 ET

HSBC Adjusts Price Target on Amgen to $356 From $322

MT NewswiresMay 20 07:48 ET

Novavax (NVAX) Was Upgraded to a Hold Rating at J.P. Morgan

TipRanksMay 17 08:15 ET

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Dynavax (DVAX) and Natera (NTRA)

TipRanksMay 14 13:30 ET